Anti-inflammatory, analgesic and anti-pyretic effects of d-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid (M-5011), a new non-steroidal anti-inflammatory drug, in rats and guinea pigs

Japanese Journal of Pharmacology

Volumn 76, Issue 1, 1998, Pages 75-86

  Kido, Hiroko ^a   Murakami, Naofumi ^a   Ito, Atsuko ^a   Kimura, Kazuo ^a   Kodera, Nobuo ^a   Doi, Takaaki ^a   Naruse, Tomohiro ^a  

^a Maruho Co   (Japan)

Author keywords

M 5011; Non steroidal anti inflammatory drug; Ulcerogenic activity

Indexed keywords

2 [4 (3 METHYL 2 THIENYL)PHENYL]PROPIONIC ACID; CARRAGEENAN; DICLOFENAC; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ERYTHEMA; GUINEA PIG; HYPERALGESIA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAIN; PAW EDEMA; PROSTAGLANDIN SYNTHESIS; RAT; ULCEROGENESIS; ULTRAVIOLET RADIATION;

EID: 0031940519     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.76.75     Document Type: Article

References (23)

1. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol) 231, 232-235 (1971)
2. Smith JB and Willis AL: Aspirin selectively inhibits prostaglandin production in human platelets. Nature (New Biol) 231, 235-237 (1971)
3. Fitzpatrick FA and Wynalda MA: In vivo suppression of prostaglandin biosynthesis by non-steroidal anti-inflammatory agents. Prostaglandins 12, 1037-1051 (1976)
4. 2 on gastric ulcers induced by non-steroidal anti-inflammatory compounds (NOSAC). Gastroenterol Jpn 16, 600-603 (1981)
5. Brunton LL: Agents for control of gastric acidity and treatment of peptic ulcers. In Goodman and Gilman's The Pharmacological Basis of Therapeutics (eighth edition), Edited by Gilman AG, Rail TW, Nies AS and Taylar P, pp 897-913, Pergamon Press, New York (1990)
6. Murakami N, Takase H, Tomita T, Iwata K and Naruse T: Antinociceptive activity of a novel non-steroidal anti-inflammatory drug (M-5011) with low ulcerogenic effects in mice. Jpn J Pharmacol 72, 29-37 (1996)
7. Winder CV, Wax J, Burr V, Been M and Rosiere CE: A study of pharmacological influences on ultraviolet erythema in guinea pigs. Arch Int Pharmacodyn Ther 116, 261-292 (1958)
8. Winter CA, Risley EA and Nuss GW: Carrageenin-induced edema in hind paw of the rat as an asssay for antiinflammatory drugs. Proc Soc Exp Biol Med 111, 544-547 (1962)
9. Randall LO and Selitto JJ: A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111, 409-419 (1957)
10. Kuzuna S and Kawai K: Evaluation of analgesic agents in rats with adjuvant arthritis. Chem Pharm Bull (Tokyo) 23, 1184-1191 (1975)
11. Domenjoz R: The pharmacology of phenylbutazone analogues. Ann NY Acad Sci 86, 263-291 (1960)
12. Imayoshi T, Iwahisa I, Terasawa M and Maruyama Y: Effects of pranoprofen (Niflan®) on inflammatory pain and prostaglandin biosynthesis in rats. Jpn J Inflammation 4, 223-227 (1984) (Abstr in English)
13. Kiyomiya K, Yamaki K, Nimura N, Kinoshita T and Oh-ishi S: Phorbol myristate acetate-stimulated release of cyclooxygenase products in rat pleural cells: derivatization of prostaglandin with 9-anthryldiazomethane for fluorometric determination by high performance liquid chromatography. Prostaglandins 31, 71-82 (1986)
14. Yamauchi Y, Tomita T and Senda M: High-performance liquid chromatographic analysis of arachidonic acid metabolites by pre-column derivatization using 9-anthryldiazomethane. J Chromatogr 357, 199-205 (1986)
15. Yamaura T, Numoto T and Tosaka K: A new experimental model for analysis of gastrointestinal injuries induced by acid non-steroidal antiinflammatory agents (ANSAIC). J Med Soc Toho Univ 29, 358-384 (1982)
16. Tsurumi K, Kyuki K, Niwa M, Doke R and Fujimura H: Pharmacology of 2-[4-(2-thiazolyloxy)-phenyl]-propionic acid (480156-S), a new non-steridal anti-inflammatory agent (3). Gastrointestinal damage and drug interaction. Pharmacometrics 30, 1019-1026 (1985) (Abstr in English)
17. 2. Prostaglandins 16, 31-37 (1978)
18. Moncada S, Ferreira SH and Vane JR: Pain and inflammatory mediators. In Inflammation, Edited by Vane JR and Ferreira SH, pp 588-616, Springer, New York (1978)
19. Pircio AW, Fedele CT and Bierwagen ME: A new method for the evaluation of analgesic activity using adjuvant-induced arthritis in the rat. Eur J Pharmacol 31, 207-215 (1975)
20. Dubinsky B, Gebre-Mariam S, Capetola RJ and Rosenthale ME: The antialgesic drugs: Human therapeutic correlates of their potency in laboratory animal models of hyperalgesia. Agents Action 20, 50-60 (1987)
21. Cremer JE and Blight J: Body-temperature and responses to drugs. Br Med Bull 25, 299-306 (1969)
22. Xie W, Robertson DL and Simmons DL: Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal anti-inflammatory drugs. Drug Dev Res 25, 249-265 (1992)
23. Tobetto K, Yamamoto Y, Kataoka M, Ando T, Sugimoto K and Himeno M: The effects of a newly developed nonsteroidal anti-inflammatory drug (M-5011) on arachidonic acid metabolism in rheumatoid synovial fibroblasts. Jpn J Pharmacol 75, 371-379 (1997)